Edition:
India

Genocea Biosciences Inc (GNCA.OQ)

GNCA.OQ on NASDAQ Stock Exchange Global Market

0.78USD
19 Jul 2018
Change (% chg)

-- (--)
Prev Close
$0.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
202,660
52-wk High
$6.77
52-wk Low
$0.75

Latest Key Developments (Source: Significant Developments)

Genocea Biosciences Files For Mixed Shelf Of Up To $200 Mln
Tuesday, 22 May 2018 

May 21 (Reuters) - Genocea Biosciences Inc ::GENOCEA BIOSCIENCES INC - FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING.  Full Article

Genocea Biosciences Enters Into Term Loan Facility Of $14 Million With Hercules
Tuesday, 1 May 2018 

April 30 (Reuters) - Genocea Biosciences Inc ::GENOCEA BIOSCIENCES INC - ON APRIL 24, CO ENTERED INTO TERM LOAN FACILITY OF $14 MILLION WITH HERCULES.GENOCEA BIOSCIENCES INC - TERM LOAN WILL MATURE ON MAY 1, 2021.  Full Article

Genocea Files IND For Neoantigen Cancer Vaccine Candidate Gen-009
Monday, 30 Apr 2018 

April 30 (Reuters) - Genocea Biosciences Inc ::GENOCEA - FILES IND FOR NEOANTIGEN CANCER VACCINE CANDIDATE GEN-009, PLANS TO INITIATE PHASE 1/2A CLINICAL PROGRAM LATER THIS YEAR.GENOCEA - TOP-LINE IMMUNE RESPONSE DATA FROM STUDY EXPECTED IN THE FIRST HALF OF 2019.  Full Article

New Enterprise Associates 16 Reports A 39.7 Pct Stake In Genocea Biosciences As Of Jan 17
Saturday, 27 Jan 2018 

Jan 26 (Reuters) - Genocea Biosciences Inc ::NEW ENTERPRISE ASSOCIATES 16, L.P. REPORTS A 39.7 PERCENT STAKE IN GENOCEA BIOSCIENCES INC AS OF JAN 17 - SEC FILING.  Full Article

Genocea Biosciences Announces Proposed Concurrent Public Offerings Of Common Stock
Wednesday, 17 Jan 2018 

Jan 16 (Reuters) - Genocea Biosciences Inc ::GENOCEA BIOSCIENCES, INC. ANNOUNCES PROPOSED CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND CLASS A WARRANTS AND SERIES A CONVERTIBLE PREFERRED STOCK AND CLASS A WARRANTS.GENOCEA BIOSCIENCES INC - ‍GENOCEA INTENDS TO USE NET PROCEEDS FROM CONCURRENT OFFERINGS TO SUPPORT ONGOING DEVELOPMENT OF ITS GEN-009 PROGRAM​.  Full Article

Genocea Biosciences inc qtrly ‍loss per share $0.59​
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Genocea Biosciences Inc :Genocea reports third quarter 2017 financial results.Genocea biosciences - ‍expects existing cash and cash equivalents sufficient to support operating expenses and capital expenditure into middle of 2018​.Genocea biosciences inc - ‍cash and cash equivalents as of september 30, 2017 were $22.0 million compared to $35.2 million as of june 30, 2017​.Genocea biosciences inc qtrly ‍loss per share $0.59​.Q3 earnings per share view $-0.53 -- Thomson Reuters I/B/E/S.  Full Article

Genocea qtrly loss per share $0.39
Thursday, 4 Aug 2016 

Genocea Biosciences Inc : Genocea reports second quarter 2016 financial results . Qtrly loss per share $0.39 .Expects that cash, cash equivalents to be sufficient to fund operating expenses, capex requirements into second half of 2017.  Full Article

BRIEF-Genocea Biosciences Files For Mixed Shelf Of Up To $200 Mln

* GENOCEA BIOSCIENCES INC - FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING Source text: (https://bit.ly/2GBQyfr) Further company coverage: